Skip to Content

International Journal of Neonatal Screening, Volume 6, Issue 4

2020 December - 21 articles

Cover Story: Dr. Lorey was a strong advocate for newborn screening and in his honor, we recognize that his seminal contributions undoubtedly have improved the quality of life of countless newborns and their families nationally and internationally. He worked with many family organizations, such as Save Babies Through Screening Foundation, to create and translate the tools needed to realize the promise of early diagnosis and treatment to save newborn lives (The photo courtesy of Dr. Lorey's family). View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (21)

  • Article
  • Open Access
4 Citations
3,551 Views
8 Pages

At-Risk Testing for Pompe Disease Using Dried Blood Spots: Lessons Learned for Newborn Screening

  • Zoltan Lukacs,
  • Petra Oliva,
  • Paulina Nieves Cobos,
  • Jacob Scott and ,
  • Thomas P. Mechtler and
  • David C. Kasper
  • + 1 author+ 0 author

Pompe disease (GSD II) is an autosomal recessive disorder caused by deficiency of the lysosomal enzyme acid-α-glucosidase (GAA, EC 3.2.1.20), leading to generalized accumulation of lysosomal glycogen especially in the heart, skeletal, and smoot...

(This article belongs to the Special Issue Newborn Screening for Pompe Disease)
  • Article
  • Open Access
16 Citations
11,398 Views
12 Pages

Philippine Performance Evaluation and Assessment Scheme (PPEAS): Experiences in Newborn Screening System Quality Improvement

  • Carmencita D. Padilla,
  • Bradford L. Therrell,
  • Karen Asuncion R. Panol,
  • Riza Concordia N. Suarez and ,
  • Ma. Elouisa L. Reyes,
  • Charity M. Jomento,
  • Ebner Bon G. Maceda,
  • Jovy Ann C. Lising,
  • Frederick David E. Beltran and
  • Lita L. Orbillo
  • + 5 authors+ 0 author

Newborn Bloodspot Screening (NBS) has existed for over 60 years, having been initiated by Guthrie in the U.S. In the Philippines, NBS was introduced in 1996 and later was supported by legislation. The NBS program now includes 29 conditions, covering...

(This article belongs to the Special Issue Newborn Screening: Promoting Quality to Optimise Benefit and Reduce Harm)
  • Article
  • Open Access
12 Citations
4,522 Views
20 Pages

The Methodological Quality and Challenges in Conducting Economic Evaluations of Newborn Screening: A Scoping Review

  • Pasquale Cacciatore,
  • Laurenske A. Visser,
  • Nasuh Buyukkaramikli,
  • Catharina P. B. van der Ploeg and
  • M. Elske van den Akker-van Marle

Cost-effectiveness (CEA) and cost–utility analyses (CUA) have become popular types of economic evaluations (EE) used for evidence-based decision-making in healthcare resource allocation. Newborn screening programs (NBS) can have significant cli...

(This article belongs to the Special Issue Economic Evaluations of Newborn Screening: Methodological Considerations and Applications)
  • Article
  • Open Access
20 Citations
5,289 Views
16 Pages

Glutaric aciduria type 1, homocystinuria, isovaleric acidaemia, long-chain hydroxyacyl CoA dehydrogenase deficiency and maple syrup urine disease are all inborn errors of metabolism that can be detected through newborn bloodspot screening. This evalu...

(This article belongs to the Special Issue Economic Evaluations of Newborn Screening: Methodological Considerations and Applications)
  • Commentary
  • Open Access
19 Citations
3,837 Views
5 Pages

Newborn Screening for Mucopolysaccharidosis I: Moving Forward Learning from Experience

  • Lorne A. Clarke,
  • Patricia Dickson,
  • N. Matthew Ellinwood and
  • Terri L. Klein

There have been significant advances allowing for the integration of mucopolysaccharidosis I into newborn screening programs. Initial experiences using a single-tier approach for this disorder have highlighted shortcomings that require immediate reme...

(This article belongs to the Special Issue Neonatal Screening for Mucopolysaccharidoses)
  • Article
  • Open Access
5 Citations
3,921 Views
9 Pages

In 2015, the newborn screening (NBS) programmes in England and Wales were expanded to include four additional disorders: Classical Homocystinuria, Isovaleric Acidemia, Glutaric Aciduria Type 1 and Maple Syrup Urine Disease, bringing the total number...

(This article belongs to the Special Issue Newborn Screening: Promoting Quality to Optimise Benefit and Reduce Harm)
  • Article
  • Open Access
43 Citations
7,304 Views
17 Pages

Newborn Screening for Pompe Disease: Pennsylvania Experience

  • Can Ficicioglu,
  • Rebecca C. Ahrens-Nicklas,
  • Joshua Barch,
  • Sanmati R. Cuddapah and ,
  • Brenda S. DiBoscio,
  • James C. DiPerna,
  • Patricia L. Gordon,
  • Nadene Henderson,
  • Caitlin Menello and
  • Rui Xiao
  • + 7 authors+ 2 authors

Pennsylvania started newborn screening for Pompe disease in February 2016. Between February 2016 and December 2019, 531,139 newborns were screened. Alpha-Glucosidase (GAA) enzyme activity is measured by flow-injection tandem mass spectrometry (FIA/MS...

(This article belongs to the Special Issue Newborn Screening for Pompe Disease)
  • Review
  • Open Access
10 Citations
4,195 Views
9 Pages

Neonatal Screening for MPS Disorders in Latin America: A Survey of Pilot Initiatives

  • Francyne Kubaski,
  • Inês Sousa,
  • Tatiana Amorim,
  • Danilo Pereira and ,
  • Joe Trometer,
  • Alexandre Souza,
  • Enzo Ranieri,
  • Giulia Polo,
  • Alberto Burlina and
  • Roberto Giugliani
  • + 8 authors+ 3 authors

Newborn screening enables the diagnosis of treatable disorders at the early stages, and because of its countless benefits, conditions have been continuously added to screening panels, allowing early intervention, aiming for the prevention of irrevers...

(This article belongs to the Special Issue Neonatal Screening for Mucopolysaccharidoses)
  • Article
  • Open Access
5 Citations
4,579 Views
12 Pages

A Biochemical Platform to Define the Relative Specific Activity of IDUA Variants Identified by Newborn Screening

  • Seok-Ho Yu,
  • Laura Pollard,
  • Tim Wood,
  • Heather Flanagan-Steet and
  • Richard Steet

The lysosomal storage disorder, mucopolysaccharidosis I (MPSI), results from mutations in IDUA, the gene that encodes the glycosaminoglycan-degrading enzyme α-L-iduronidase. Newborn screening efforts for MPSI have greatly increased the number o...

(This article belongs to the Special Issue Neonatal Screening for Mucopolysaccharidoses)
  • Article
  • Open Access
16 Citations
5,103 Views
13 Pages

Instability of Acylcarnitines in Stored Dried Blood Spots: The Impact on Retrospective Analysis of Biomarkers for Inborn Errors of Metabolism

  • Willemijn J. van Rijt,
  • Peter C. J. I. Schielen,
  • Yasemin Özer,
  • Klaas Bijsterveld and ,
  • Fjodor H. van der Sluijs,
  • Terry G. J. Derks and
  • M. Rebecca Heiner-Fokkema
  • + 2 authors+ 0 author

Stored dried blood spots (DBS) can provide valuable samples for the retrospective diagnosis of inborn errors of metabolism, and for validation studies for newborn blood spot screening programs. Acylcarnitine species are subject to degradation upon lo...

  • Review
  • Open Access
60 Citations
11,144 Views
16 Pages

Development of Strategies to Decrease False Positive Results in Newborn Screening

  • Sabrina Malvagia,
  • Giulia Forni,
  • Daniela Ombrone and
  • Giancarlo la Marca

The expansion of national newborn screening (NBS) programmes has provided significant benefits in the diagnosis and early treatment of several rare, heritable conditions, preventing adverse health outcomes for most affected infants. New technological...

(This article belongs to the Special Issue Newborn Screening: Promoting Quality to Optimise Benefit and Reduce Harm)
  • Article
  • Open Access
17 Citations
5,934 Views
14 Pages

Report of Five Years of Experience in Neonatal Screening for Mucopolysaccharidosis Type I and Review of the Literature

  • Vincenza Gragnaniello,
  • Daniela Gueraldi,
  • Laura Rubert,
  • Francesca Manzoni and ,
  • Chiara Cazzorla,
  • Antonella Giuliani,
  • Giulia Polo,
  • Leonardo Salviati and
  • Alberto Burlina
  • + 4 authors+ 0 author

Mucopolysaccharidosis type I (MPS I) is a progressive lysosomal storage disease, with neurological and visceral involvement, in which early diagnosis through newborn screening (NBS) and early treatment can improve outcomes. We present our first 5 yea...

(This article belongs to the Special Issue Neonatal Screening for Mucopolysaccharidoses)
  • Review
  • Open Access
19 Citations
5,780 Views
19 Pages

Generalizing about the cost-effectiveness of newborn screening (NBS) is difficult due to the heterogeneity of disorders included in NBS panels, along with data limitations. Furthermore, it is unclear to what extent evidence about cost-effectiveness s...

(This article belongs to the Special Issue Economic Evaluations of Newborn Screening: Methodological Considerations and Applications)
  • Article
  • Open Access
30 Citations
3,933 Views
8 Pages

Newborn Screening for X-Linked Adrenoleukodystrophy in Georgia: Experiences from a Pilot Study Screening of 51,081 Newborns

  • Patricia L. Hall,
  • Hong Li,
  • Arthur F. Hagar,
  • S. Caleb Jerris and ,
  • Angela Wittenauer and
  • William Wilcox
  • + 1 author+ 0 author

We screened 51,081 newborns for X-linked adrenoleukodystrophy (ALD) using a two-tiered strategy quantifying very long chain lysophosphatadylcholines (LPC). Our testing strategy used flow injection tandem mass spectrometry for the first-tier analysis...

  • Review
  • Open Access
31 Citations
5,281 Views
12 Pages

Translating Molecular Technologies into Routine Newborn Screening Practice

  • Sarah M. Furnier,
  • Maureen S. Durkin and
  • Mei W. Baker

As biotechnologies advance and better treatment regimens emerge, there is a trend toward applying more advanced technologies and adding more conditions to the newborn screening (NBS) panel. In the current Recommended Uniform Screening Panel (RUSP), a...

(This article belongs to the Special Issue Newborn Screening: Promoting Quality to Optimise Benefit and Reduce Harm)
  • Article
  • Open Access
17 Citations
5,313 Views
13 Pages

Mucopolysaccharidosis Type II (MPS II), also known as Hunter syndrome, is a lysosomal storage disorder (LSD) caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase (IDS). MPS II satisfies all criteria defined by the Advisory Committee o...

(This article belongs to the Special Issue Neonatal Screening for Mucopolysaccharidoses)
  • Review
  • Open Access
32 Citations
5,847 Views
12 Pages

Considering Proximal Urea Cycle Disorders in Expanded Newborn Screening

  • Tania Vasquez-Loarte,
  • John D. Thompson and
  • J. Lawrence Merritt

Proximal urea cycle disorders (PUCDs) have adverse outcomes such as intellectual disability and death, which may benefit from newborn screening (NBS) through early detection and prevention with early treatment. Ornithine transcarbamylase deficiency (...

  • Review
  • Open Access
14 Citations
4,201 Views
11 Pages

Newborn screening (NBS) for mucopolysaccharidosis type I (MPS I, Hurler syndrome) is currently conducted in about two-fifths of the NBS programs in the United States and in a few other countries. Screening is performed by measurement of residual acti...

(This article belongs to the Special Issue Neonatal Screening for Mucopolysaccharidoses)
  • Article
  • Open Access
24 Citations
8,650 Views
31 Pages

We All Have a Role to Play: Redressing Inequities for Children Living with CAH and Other Chronic Health Conditions of Childhood in Resource-Poor Settings

  • Kate Armstrong,
  • Alain Benedict Yap,
  • Sioksoan Chan-Cua,
  • Maria E. Craig and ,
  • Catherine Cole,
  • Vu Chi Dung,
  • Joseph Hansen,
  • Mohsina Ibrahim,
  • Hassana Nadeem and
  • Paul Ward
  • + 8 authors+ 3 authors

CLAN (Caring and Living as Neighbours) is an Australian-based non-governmental organisation (NGO) committed to equity for children living with chronic health conditions in resource-poor settings. Since 2004, CLAN has collaborated with a broad range o...

(This article belongs to the Special Issue CAH Screening—Challenges and Opportunities)
XFacebookLinkedIn
Int. J. Neonatal Screen. - ISSN 2409-515X